Heparin. New biochemical and medical aspects : : Proceedings of the symposium of the Deutsche Gesellschaft für Klinische Chemie, Titisee, Breisgau, Germany June 29th–July 1st, 1981 / / ed. by Irene Witt.

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990
MitwirkendeR:
HerausgeberIn:
Place / Publishing House:Berlin ;, Boston : : De Gruyter, , [2019]
©1983
Year of Publication:2019
Edition:Reprint 2019
Language:English
Online Access:
Physical Description:1 online resource (372 p.) :; Num. figs.
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Preface
  • Introductory Welcome
  • List Of Participants
  • Contents
  • I. Heparin: Structure, Mechanism of Action, Biosynthesis and Catabolism
  • The Function and Structure of the Heparin Molecule
  • Biosynthesis of Heparin
  • Physiological Heparin - its Function and Fate
  • Mechanism of Heparin Rebound and Heparin-Protamine Interactions
  • II. Methods for the Determination of Heparin
  • Overview on Methods for the Determination of Heparin
  • Control of Heparin Therapy by Measurement of the Antithrombin III-Heparin-Complex
  • Determination of Heparin by a Fluorogenic Synthetic Substrate
  • Properties of the Coatest ® Heparin As say
  • A Sensitive Competitive Binding Assay for Heparin
  • Determination of Low Dose Heparin Activities in Plasma
  • Characterization of Heparin Preparations in Vivo by Different Test Systems
  • Determination of Heparin and Fractionated Heparin with Different Molecular Weights
  • III. Clinical Usage of Heparin
  • Low Molecular Weight Heparin and the Prevention of Postoperative Deep Vein Thrombosis
  • The Effect of Heparins on Platelet Release Reaction
  • Characterization of a New Potent Heparin
  • Side Effects of Heparin
  • Role of Heparin-Like Molecules in Atherogenesis
  • Unresolved Problems in the Use of Heparin
  • IV. Experience with "Monitoring of Heparin Therapy"
  • Heparin Treatment of Deep Venous Thrombosis: Correlation Between Clinical Effects and Heparin Assays
  • Heparin-, Heparin Cofactor- and Platelet Factor 4 Plasma Levels Under Heparin Treatment
  • Determination of Heparin, Partial Thromboplastin Time and Antithrombin III after Subcutaneous Heparin Administration
  • Monitoring of Heparin During Extracorporal Circulation in Open Heart Surgery
  • Chromogenic and Fluorogenic Assays - A Challenge for Conventional Monitoring of Heparin Therapy?
  • V. Concluding Discussion
  • Introduction
  • Subject Index